Molecule Details
| InChIKey | STWVLEKJQQRGMO-GUYCJALGSA-N |
|---|---|
| Compound Name | 5-(4-((2S,5S)-5-(4-Chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine |
| Canonical SMILES | C[C@H]1CN(C2CCN(c3nc(N)n[nH]3)CC2)[C@@H](Cc2ccc(Cl)cc2)CO1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.94 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB18065 |
|---|---|
| Drug Name | 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine |
| CAS Number | 2088453-21-6 |
| Groups | investigational |
| ATC Codes | nan |
| Description | nan |
Categories: Enzyme Inhibitors Protein Kinase Inhibitors
Cross-references: CHEMBL4788866 ChemSpider: 114877003 PDB: QGB